Correction: Fixed-duration therapy of chronic lymphocytic leukemia with venetoclax and Bruton tyrosine kinase inhibitors: an insight into differences between ibrutinib and acalabrutinib

<p>Leukemia, Published online: 03 November 2025; <a href="https://www.nature.com/articles/s41375-025-02793-2">doi:10.1038/s41375-025-02793-2</a></p>Correction: Fixed-duration therapy of chronic lymphocytic leukemia with venetoclax and Bruton tyrosine kinase inhibitors: an insight into differences between ibrutinib and acalabrutinib